OCT4: biological functions and clinical applications as a marker of germ cell neoplasia - PubMed

Review

OCT4: biological functions and clinical applications as a marker of germ cell neoplasia

L Cheng et al. J Pathol. 2007 Jan.

Abstract

Germ cell tumours (GCTs) are a heterogeneous group of neoplasms, which develop in the gonads as well as in extragonadal sites, that share morphological patterns and an overall good prognosis, owing to their responsiveness to current surgical, chemotherapeutic, and radiotherapeutic measures. GCTs demonstrate extremely interesting biological features because of their close relationships with normal embryonal development as demonstrated by the pluripotentiality of some undifferentiated GCT variants. The similarities between GCTs and normal germ cell development have made it possible to identify possible pathogenetic pathways in neoplastic transformation and progression of GCTs. Genotypic and immunophenotypic profiles of these tumours are also useful in establishing and narrowing the differential diagnosis in cases of suspected GCTs. Recently, OCT4 (also known as OCT3 or POU5F1), a transcription factor that has been recognized as fundamental in the maintenance of pluripotency in embryonic stem cells and primordial germ cells, has been proposed as a useful marker for GCTs that exhibit features of pluripotentiality, specifically seminoma/dysgerminoma/germinoma and embryonal carcinoma. The development of commercially available OCT4-specific antibodies suitable for immunohistochemistry on paraffin-embedded specimens has generated increasing numbers of reports of OCT4 expression in a wide variety of gonadal and extragonadal GCTs. OCT4 immunostaining has been shown to be a sensitive and specific marker for seminomatous/(dys)germinomatous tumours and in embryonal carcinoma variants of non-seminomatous GCTs, whether in primary gonadal or extragonadal sites or in metastatic lesions. Therefore, OCT4 immunohistochemistry is an additional helpful marker both in the differential diagnosis of specific histological subtypes of GCTs and in establishing a germ cell origin for some metastatic tumours of uncertain primary. OCT4 expression has also been reported in pre-invasive conditions such as intratubular germ cell neoplasia, unclassified (IGCNU) and the germ cell component of gonadoblastoma. Additionally, OCT4 immunostaining shows promise as a useful tool in managing patients known to be at high risk for the development of invasive GCTs.

Similar articles

• OCT4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis.

  Jones TD, Ulbright TM, Eble JN, Cheng L. Jones TD, et al. Clin Cancer Res. 2004 Dec 15;10(24):8544-7. doi: 10.1158/1078-0432.CCR-04-0688. Clin Cancer Res. 2004. PMID: 15623637

• Screening for intratubular germ cell neoplasia of the testis using OCT4 immunohistochemistry.

  Jones TD, MacLennan GT, Bonnin JM, Varsegi MF, Blair JE, Cheng L. Jones TD, et al. Am J Surg Pathol. 2006 Nov;30(11):1427-31. doi: 10.1097/01.pas.0000213288.50660.f7. Am J Surg Pathol. 2006. PMID: 17063084

• Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours.

  de Jong J, Stoop H, Dohle GR, Bangma CH, Kliffen M, van Esser JW, van den Bent M, Kros JM, Oosterhuis JW, Looijenga LH. de Jong J, et al. J Pathol. 2005 Jun;206(2):242-9. doi: 10.1002/path.1766. J Pathol. 2005. PMID: 15818593

• Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.

  Looijenga LH. Looijenga LH. J Pathol. 2009 Jun;218(2):146-62. doi: 10.1002/path.2522. J Pathol. 2009. PMID: 19253916 Review.

Cited by

• TRA-1-60⁺, SSEA-4⁺, Oct4A⁺, Nanog⁺ Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Ovaries.

  Malecki M, Anderson M, Beauchaine M, Seo S, Tombokan X, Malecki R. Malecki M, et al. J Stem Cell Res Ther. 2012 Nov 18;2(5):130. J Stem Cell Res Ther. 2012. PMID: 23293749 Free PMC article.

• SALL4 is a useful marker in the diagnostic work-up of germ cell tumors in extra-testicular locations.

  Camparo P, Comperat EM. Camparo P, et al. Virchows Arch. 2013 Mar;462(3):337-41. doi: 10.1007/s00428-012-1353-5. Epub 2012 Dec 9. Virchows Arch. 2013. PMID: 23224120

• [Molecular pathology of testicular germ cell tumors: an update].

  Biermann K, Zhou H, Büttner R. Biermann K, et al. Pathologe. 2008 Sep;29(5):348-53. doi: 10.1007/s00292-008-1014-2. Pathologe. 2008. PMID: 18633620 German.

• Testicular germ cell tumors: a clinicopathological and immunohistochemical analysis of 145 cases.

  Zhang T, Ji L, Liu B, Guan W, Liu Q, Gao Y. Zhang T, et al. Int J Clin Exp Pathol. 2018 Sep 1;11(9):4622-4629. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31949861 Free PMC article.

• Synthetic and immunological studies on the OCT4 immunodominant motif antigen-based anti-cancer vaccine.

  Chen T, Liu K, Xu J, Zhan T, Liu M, Li L, Yang Z, Yuan S, Zou W, Lin G, Carson DA, Wu CCN, Wang X. Chen T, et al. Cancer Biol Med. 2020 Feb 15;17(1):132-141. doi: 10.20892/j.issn.2095-3941.2019.0224. Cancer Biol Med. 2020. PMID: 32296581 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley